Quality Policy 

IC Products SA is committed to the development, manufacture, and supply of disinfectants for medical devices and biocidal products that meet the highest standards of quality, safety, and regulatory compliance. 

As a Swiss-based manufacturer operating in Switzerland and the European market, IC Products SA complies with all applicable national and international regulations, including ISO 13485 and Regulation (EU) 2017/745 (Medical Device Regulation), as well as other relevant legal and regulatory requirements. 

During the transition period, IC Products SA places products on the market in accordance with the applicable transitional provisions of Regulation (EU) 2017/745. 

The company applies a risk-based approach throughout the entire product lifecycle to ensure that risks to patients, users, and third parties are identified, evaluated, and controlled, while maintaining a positive and acceptable benefit–risk profile for its products. 

IC Products SA is committed to: 

• ensuring the safety, performance, and quality of its products; 

• meeting applicable regulatory and customer requirements; 

• maintaining and continuously improving the effectiveness of its Quality Management System; 

• integrating quality and regulatory compliance into all stages of product realization and post-market activities; 

• promoting competence, awareness, and responsibility among its personnel through appropriate training and continuous development; 

• fostering transparent and effective communication with customers, authorities, suppliers, and other relevant stakeholders. 
  
  

For markets outside Switzerland and the European Union, local distributors are responsible for ensuring compliance with applicable national regulatory and registration requirements. 

Top management is fully committed to providing the necessary resources to support these principles and to ensure the long-term sustainability and reliability of the company. 

Eszter Jakab 
Chief Executive Officer 
IC Products SA